Literature DB >> 11287684

Gene therapy for HIV.

A M Lever1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287684      PMCID: PMC1744275          DOI: 10.1136/sti.77.2.93

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  48 in total

Review 1.  A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides.

Authors:  A A Levin
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

Authors:  B A Sullenger; H F Gallardo; G E Ungers; E Gilboa
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

3.  cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails.

Authors:  E Olivetta; K Pugliese; R Bona; P D'Aloja; F Ferrantelli; A C Santarcangelo; G Mattia; P Verani; M Federico
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Gene therapy. Intracellular immunization.

Authors:  D Baltimore
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

5.  Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model.

Authors:  M Andäng; J Hinkula; G Hotchkiss; S Larsson; S Britton; F Wong-Staal; B Wahren; L Ahrlund-Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.

Authors:  D P Bednarik; J D Mosca; N B Raj; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

Authors:  A Rhodes; W James
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

9.  Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA.

Authors:  G Sczakiel; M Pawlita
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression.

Authors:  S Joshi; A Van Brunschot; S Asad; I van der Elst; S E Read; A Bernstein
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.